New patent for Reata Pharms drug SKYCLARYSBy DrugPatentWatch – Make Better Decisions / April 5, 2024 Annual Drug Patent Expirations for SKYCLARYS Skyclarys is a drug marketed by Reata Pharms and is included in one NDA. It is available from one supplier. There are six patents…Source